N/A N=194 Computer-Based Weight Maintenance in Primary Care
Body Weight · Weight Loss · Motor Activity
Primary: Body Weight — 2.07; 4.93 kg
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=109 Transcutaneous Electrical Nerve Stimulation (TENS) for Pain Control During First Trimester Abortion
Abortion in First Trimester
Primary: Aspiration Pain — 73; 66 units on a scale
N/A N=65 The EndoGastric Solutions TEMPO Trial
Gastroesophageal Reflux Disease (GERD)
Primary: Number of Participants Reporting GERD (Gastroesophageal Reflux Disease) Symptom Elimination or Clinically Significant Improvement Evaluated by RSI (Reflux Symptom Index)…
Phase 2 N=284 Non-Myeloablative Conditioning for Unrelated Donor Umbilical Cord Blood Transplant
Myeloproliferative Disorders · Leukemia · Lymphoma
Primary: Number of Participants Who Were Alive at 1 Year Post Transplant — 59; 40; 1; 26 Participants
Phase 2 N=60 A Pharmacokinetics, Safety and Efficacy Study of Tafenoquine (TQ) in Pediatric Subjects With Plasmodium Vivax (P. Vivax) Malaria
Malaria, Vivax
Primary: Area Under the Curve From Time 0 Extrapolated to Infinite Time (AUC[0-infinity]) of Tafenoquine by Weight Band in Participants Aged >=2 Years to <16 Years (Weighing >=5…
Phase 2 N=39 Using Multiparametric MRI to Evaluate Intraprostatic Tumor Responses and Androgen Resistance Patterns in Newly Diagnosed Prostate Cancer
Prostate Cancer
Primary: Median Tumor Volume Burden at Baseline Multi-parametric Magnetic Resonance Imaging (mpMRI) Before and After Surgery — 3.44; 0.62 cc
N/A N=211 PREVAIL-TF: Transfemoral Placement of Aortic Balloon Expandable Transcatheter Valves Trial (Europe)
Aortic Valve Stenosis
Primary: Number of Deaths — 21 Participants
Phase 2 N=358 A Multi-Center Controlled Screening Trial of Safety and Efficacy of Lithium Carbonate in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Amyotrophic Lateral Sclerosis
Primary: Change in Monthly Rate of Decline in ALSFRS-R (Amyotrophic Lateral Sclerosis Functional Rating Score - Revised) — 1.20; 1.01 points per month
N/A N=101 Remote Ischemic Preconditioning and Contrast Induced - Acute Kidney Injury in Patients Undergoing Elective PCI
Remote Ischemic Preconditioning · Contrast Induced - Acute Kidney Injury
Primary: Number of Participants With Contrast Induced-Acute Kidney Injury — 2; 3 participants
N/A N=57 Safety and Efficacy of TrueTear™ for the Treatment of Meibomian Gland Disease
Meibomian Glands · Dry Eye Syndromes
Primary: Change From Baseline in Meibomian Gland Dysfunction (MGD) Impact Questionnaire Score — -0.4; -0.3; -0.4; -0.2 score on scale — p=0.9788
N/A N=120 A Clinical Study to Assess the Effects of Various Dentifrice Technologies on Dentinal Hypersensitivity
Dentin Hypersensitivity
Primary: Air Challenge — 1.17; 1.48; 2.26; 1.39 score on a scale
N/A N=2,244 Evaluation of ACUITY™ X4 Quadripolar Coronary Venous Leads and RELIANCE™ 4-FRONT Defibrillation Leads
Cardiac Resynchronization Therapy
Primary: Percentage of ACUITY X4 Spiral Leads Free From Complication Through 6 Months — 98.5 % of leads free from complication
Phase 3 N=428 Evaluation of the Effectiveness and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Have Active Disease
Rheumatoid Arthritis
Primary: Percentage of Subjects Achieving American College of Rheumatology 20% (ACR20) Response — 100; 91; 37 Participants — p=<0.0001
Phase 4 N=65 Efficacy Study of Vaginal Mesh for Anterior Prolapse
Vaginal Prolapse · Uterine Prolapse · Cystocele
Primary: The Primary Outcome Measure for Objective Treatment Success is Anterior Prolapse, Point Ba at Stage 0 or 1 (Defined as Maximal Descent of the Anterior Wall to Greater…
Phase 2 N=36 Tocilizumab in the Treatment of Refractory Polymyositis and Dermatomyositis
Dermatomyositis · Polymyositis
Primary: Compare the Average Total Improvement Scores at Visits 2 Through 7 During the 6-month Treatment Period Between the Treatment and Placebo Arms — 26.4; 29.3 score on a…